Key facts
- Pharma Solutions’s last known valuation is $35.0M (Apr 2026).
- It has raised $14.6M; the latest was Later Stage VC ($7.9M) in Apr 2026.
- Notable investors include The Legal Tech Fund, BluePointe Ventures, Bertelsmann, Eileses Capital, Founders First CDC — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Pharma Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Pharma Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pharma Solutions
Operator of a consulting company intended to promote quality and security in the drug supply chain. The company offers state compliance business strategy, training courses, drug enforcement administration compliance, reporting, drug distributors, pharmacy accreditations, pharmacy, mail, and retail services, enabling the pharmaceutical industries to focus on growth.
- Sector
- Business Products and Services (B2B)
- HQ
- Philadelphia, PA, United States
- Founded
- 2016
- Employees
- 20
- Website
- pharma.solutions/
- Ownership
- Privately Held (backing)
Pharma Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pharma Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pharma Solutions in its N-PORT filings yet. We sweep new filings monthly.